JP2007501616A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501616A5
JP2007501616A5 JP2006522760A JP2006522760A JP2007501616A5 JP 2007501616 A5 JP2007501616 A5 JP 2007501616A5 JP 2006522760 A JP2006522760 A JP 2006522760A JP 2006522760 A JP2006522760 A JP 2006522760A JP 2007501616 A5 JP2007501616 A5 JP 2007501616A5
Authority
JP
Japan
Prior art keywords
tff3
seq
antibody
neutralizing agent
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006522760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007501616A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/025508 external-priority patent/WO2005013802A2/en
Publication of JP2007501616A publication Critical patent/JP2007501616A/ja
Publication of JP2007501616A5 publication Critical patent/JP2007501616A5/ja
Withdrawn legal-status Critical Current

Links

JP2006522760A 2003-08-07 2004-08-05 抗癌治療のための標的としてのトレホイル因子3(tff3) Withdrawn JP2007501616A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49317303P 2003-08-07 2003-08-07
US49843803P 2003-08-28 2003-08-28
PCT/US2004/025508 WO2005013802A2 (en) 2003-08-07 2004-08-05 Trefoil factor 3 (tff3) as a target for anti-cancer therapy

Publications (2)

Publication Number Publication Date
JP2007501616A JP2007501616A (ja) 2007-02-01
JP2007501616A5 true JP2007501616A5 (enExample) 2007-07-26

Family

ID=34138741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006522760A Withdrawn JP2007501616A (ja) 2003-08-07 2004-08-05 抗癌治療のための標的としてのトレホイル因子3(tff3)

Country Status (9)

Country Link
US (2) US20080233046A1 (enExample)
EP (1) EP1660136A4 (enExample)
JP (1) JP2007501616A (enExample)
KR (1) KR20060073589A (enExample)
AU (1) AU2004263140A1 (enExample)
CA (1) CA2534658A1 (enExample)
IL (1) IL173333A0 (enExample)
MX (1) MXPA06001327A (enExample)
WO (1) WO2005013802A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ556158A (en) * 2004-12-22 2010-04-30 Auckland Uniservices Ltd Trefoil factors and methods of treating proliferation disorders using same
US7601540B2 (en) * 2006-07-18 2009-10-13 Bristol-Myers Squibb Company Gamma secretase notch biomarkers
US20080199455A1 (en) * 2006-10-03 2008-08-21 Lobie Peter E Conformation specific antibodies that bind trefoil factors and methods of treating cancers and proliferation disorders using same
ES2332167B1 (es) * 2007-12-04 2010-10-25 Universidad Autonoma De Madrid Empleo de trefoil factor-family 3 (tff3) en el pronostico de sujetos diagnosticados con cancer colorectal.
WO2011060040A1 (en) * 2009-11-10 2011-05-19 Abraxis Bioscience, Llc Diagnostic and therapeutic applications of the u6 snrna
GB0920014D0 (en) 2009-11-13 2009-12-30 Medical Res Council Cell sampling device
US20150056641A1 (en) * 2011-01-08 2015-02-26 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2025217196A1 (en) 2024-01-31 2026-07-09 Bluerock Therapeutics Lp Igfbp2 in cell culture
CN120209138B (zh) * 2025-05-29 2025-10-03 杭州广科安德生物科技有限公司 Tff3、osm蛋白的抗体及其组合和在结直肠癌诊断中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063755A (en) * 1991-02-14 2000-05-16 The General Hospital Corporation Intestinal trefoil proteins
WO1996039419A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins
US6337195B1 (en) * 1995-06-06 2002-01-08 Human Genome Sciences, Inc. Colon specific genes and proteins
DE19701873C1 (de) * 1997-01-21 1998-06-04 Daimler Benz Ag Halterung einer Abgasrückführleitung am Motorgehäuse einer Brennkraftmaschine
US6465611B1 (en) * 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6261562B1 (en) * 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6476207B1 (en) * 1998-06-11 2002-11-05 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer
US5998148A (en) * 1999-04-08 1999-12-07 Isis Pharmaceuticals Inc. Antisense modulation of microtubule-associated protein 4 expression
FR2810297B1 (fr) * 2000-06-16 2002-08-02 Cogema Distributeur automatique de couvercles sur des boites
EP1358327A2 (en) * 2001-01-11 2003-11-05 Curagen Corporation Proteins and nucleic acids encoding same
US20030064385A1 (en) * 2001-05-16 2003-04-03 Dressman Marlene Michelle Genes expressed in breast cancer as prognostic and therapeutic targets
AU2002322280A1 (en) * 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
DE10215320A1 (de) * 2002-04-02 2003-10-23 Metagen Pharmaceuticals Gmbh Verwendungen von TFF3 bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen
CA2499709A1 (en) * 2002-06-19 2003-12-31 Yoichi Furukawa Method for diagnosis of colorectal tumors
WO2004085621A2 (en) * 2003-03-20 2004-10-07 Dana-Farber Cancer Institute, Inc. Gene expression in breast cancer

Similar Documents

Publication Publication Date Title
CN114539411B (zh) 一种ror1抗体或其抗原结合片段
KR20140107615A (ko) 엑소좀 검출용 모노클로날 항체
CA2633171A1 (en) Antibodies against tumor-associated antigenic target (tat) polypeptides
JP2002542157A5 (enExample)
DK2743697T3 (en) METHODS OF IN VITRO DIAGNOSTICS OF INVASIVE CARCINOMS
CN101245101B (zh) 抗人cd146的单克隆抗体,包含其的组合物,检测可溶性cd146的方法
JP2014530201A (ja) 抗c−Met抗体
CN116333137B (zh) 一种cd103抗体及其应用
JP6977105B2 (ja) Igf−1r抗体および癌の診断のためのその使用
EP3746477A1 (en) Compounds that modulate the interaction of vista and vsig3 and methods of making and using
CN105504060A (zh) 一种抗胃癌细胞表面功能性表达的足萼样蛋白前体亚型2的单克隆抗体及其制备方法和用途
CN112812179B (zh) 高亲和力高特异性抗cmtm6单克隆抗体及其用途
EP3963332B1 (en) Biomarkers for disease progression in squamous cell carcinoma
KR102429562B1 (ko) 간세포암 진단용 바이오마커 세레브론 및 이에 특이적인 신규한 단일클론항체
KR20110122807A (ko) 피에이유에프(pauf) 특이적인 인간 단일클론항체, 이를 포함하는 암 치료용 조성물, 이를 이용하는 암의 진단방법
CN103130896B (zh) 抗细胞表面异位表达的单克隆抗体及其制备方法和用途
US8975030B2 (en) Method for cancer detection
KR102401657B1 (ko) 동반진단용 암 조직 내 보체 c7 바이오마커 조성물 및 이의 용도
EP3288978B1 (en) Igf-1r antibody and its use for the diagnosis of cancer
CA2714880C (en) A novel tumor biomarker
JP2022501062A (ja) Epn1を標的とする抗体